Inventor
LIOU JING-PING
TW23 patents
⚠️ This page may combine multiple inventors who share the name “LIOU JING-PING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TAIPEI MEDICAL
11 patentsUS7741495B2Jun 22, 2010
Indoline-sulfonamides compounds
UNIV TAIPEI MEDICAL29 citations92
US11278523B2Mar 22, 2022
Indoline derivatives for treatment and/or prevention of fibrosis diseases
UNIV TAIPEI MEDICAL3 citations70
US11427544B2Aug 30, 2022
Histone deacetylase 6 inhibitors and use thereof
UNIV TAIPEI MEDICAL0 citations57
US11479528B2Oct 25, 2022
Heat shock protein 90 inhibitors
UNIV TAIPEI MEDICAL0 citations51
US10577328B2Mar 3, 2020
Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
UNIV TAIPEI MEDICAL0 citations51
US7560491B2Jul 14, 2009
Z-stilbenes derivatives and the pharmaceutical composition thereof
UNIV TAIPEI MEDICAL0 citations51
US10246455B2Apr 2, 2019
Histone deacetylase inhibitors
UNIV TAIPEI MEDICAL0 citations49
US9598364B2Mar 21, 2017
Indolyl or indolinyl hydroxamate compounds
UNIV TAIPEI MEDICAL0 citations48
US11903907B2Feb 20, 2024
Soluble honokiol derivatives
UNIV TAIPEI MEDICAL0 citations42
US10624897B2Apr 21, 2020
Chlorobenzene substituted azaaryl compounds
UNIV TAIPEI MEDICAL0 citations41
US10745433B2Aug 18, 2020
Compounds for inhibiting cancer and virus
UNIV TAIPEI MEDICAL0 citations34
CALGENT BIOTECHNOLOGY CO LTD
5 patentsUS11919858B2Mar 5, 2024
Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
CALGENT BIOTECHNOLOGY CO LTD0 citations60
US11084786B2Aug 10, 2021
Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
CALGENT BIOTECHNOLOGY CO LTD0 citations60
US12453708B2Oct 28, 2025
Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases
CALGENT BIOTECHNOLOGY CO LTD0 citations57
US11833122B2Dec 5, 2023
Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases
CALGENT BIOTECHNOLOGY CO LTD0 citations57
US10745350B2Aug 18, 2020
Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
CALGENT BIOTECHNOLOGY CO LTD0 citations49
NAT HEALTH RESEARCH INSTITUTES
4 patentsUS6933316B2Aug 23, 2005
Indole compounds
NAT HEALTH RESEARCH INSTITUTES53 citations92
US7456289B2Nov 25, 2008
Anti-tumor compounds
NAT HEALTH RESEARCH INSTITUTES36 citations91
US7632955B2Dec 15, 2009
Indole compounds
NAT HEALTH RESEARCH INSTITUTES10 citations83
US7528165B2May 5, 2009
Indole compounds
NAT HEALTH RESEARCH INSTITUTES13 citations83